Results for: Uncategorized

Uncategorized

Portfolio company Resilience in the news: “Resilience Subsidiary Ology Bioservices Awarded Contract Worth Up To $250 Million from U.S. Department of Defense for Botulinum Neurotoxin Treatment”

February 9, 2022

The greatest return is serving those who put their lives on the line: our nation’s high-risk public servants.